Nabla Raises $24M for AI Assistant that Automates Clinical Notes

The Paris-based startup plans to phase out OpenAI's GPT-4, focusing on fine-tuning open source models for its AI copilot that assists doctors with administrative tasks.

• Nabla, a Paris-based startup, has raised a $24 million Series B funding round led by Cathay Innovation, with participation from ZEBOX Ventures. This funding round comes just a few months after Nabla signed a large-scale partnership with Permanente Medical Group, a division of U.S. healthcare giant Kaiser Permanente.
• Nabla has been developing an AI copilot for doctors and other medical staff that automatically takes notes and writes medical reports during consultations. The AI uses speech-to-text technology to turn the conversation into a written transcript and then generates a thorough medical report with a summary of the consultation, prescriptions, and follow-up appointment letters.
• The company's AI assistant, Nabla Copilot, is not intended to replace doctors but to help them save time on administrative work, allowing them to focus more on patients.
• Nabla is planning to phase out its reliance on OpenAI's GPT-4 and focus on fine-tuning open source models, such as Facebook’s LLaMA 2. The company believes that the future lies in using a combination of different open source and homegrown models for different tasks.
• Nabla's medical note-taking software, released in March 2023, has more than 20,000 users, with around 50 percent being primary care doctors and 30 percent being psychologists and psychiatrists. The company scored a significant contract win with the Permanente Medical Group in October 2023.

4 Articles

VentureBeat TechCrunch Forbes Forbes